--- title: "ADO OncoTobee - Reviews, Revenue and Downloads in Germany | Apple App Store" description: "Die App „ADO OncoTobee“ - am Puls der Dermato-Onkologie Die App „ADO OncoTobee“ bietet Ihnen digital aufbereitete praktische Hilfestellungen und aktuelle Informationen von der Diagnostik bis zur Th" --- # ADO OncoTobee — Germany ![ADO OncoTobee App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple211/v4/54/52/39/5452398a-24e2-8b3f-fcd9-34d93e17e8ac/AppIcon-0-0-1x_U007ephone-0-1-0-85-220.jpeg/400x400bb.jpg) **Developer:** [swiss4ward Europe S.L](https://apptail.io/developer/swiss4ward-europe-sl-FSP) **Category:** Medical **Rating:** 5.0/5 (10 ratings) **Price:** Free **Bundle ID:** com.swiss4ward.Dermatooncology **Store:** Apple App Store **Country:** Germany **Version:** 2.5.8 (released 2026-10-06) **Original Release:** 2023-08-18 **App Store Link:** [Download on Apple App Store](https://apps.apple.com/de/app/app/id1661274761) **AppTail Page:** [https://apptail.io/app/ado-oncotobee-SWrn/germany](https://apptail.io/app/ado-oncotobee-SWrn/germany) ## ADO OncoTobee Description Die App „ADO OncoTobee“ - am Puls der Dermato-Onkologie Die App „ADO OncoTobee“ bietet Ihnen digital aufbereitete praktische Hilfestellungen und aktuelle Informationen von der Diagnostik bis zur Therapie maligner (auch seltener) Hauttumore. Sie ist nur für Fachkreise bestimmt und benötigt je nach Kategorie eine Doc-Check Anmeldung. Finden Sie Hilfestellungen und wichtige Informationen zu den Themen • Stadienkalkulatoren • Leitlinien Essentials • Medikamente • Praktische Tools • Materialien, SlideKits & Literatur • Fortbildungen & eCMEs • ADO-Veranstaltungen Die App soll helfen, Schritt zu halten im sich dynamisch wandelndem Feld der malignen Hauttumore. Sie dient ausschließlich als Informationsgrundlage für die Behandlung von Hautkrebserkrankungen Unsere Vision ist es: Die APP „ADO OncoTobee“ zu Ihrem einzigartigen, digitalen Berufsbegleiter im klinischen Alltag werden zu lassen. ## ADO OncoTobee Screenshots - [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/25/7a/e8/257ae8d2-90d8-7ed9-35cd-3341c2e6d5a2/Simulator_Screenshot_-_iPhone_16_Pro_Max_-_2025-02-20_at_09.44.04.png/1320x2868.png) - [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/63/93/b1/6393b104-4d4a-6499-d72c-35402178d6e9/Simulator_Screenshot_-_iPhone_16_Pro_Max_-_2025-02-20_at_09.44.28.png/1320x2868.png) - [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/36/fd/e9/36fde96c-ef8f-b48e-74f6-f80d2d8cf40c/Simulator_Screenshot_-_iPhone_16_Pro_Max_-_2025-02-20_at_09.44.01.png/1320x2868.png) ## ADO OncoTobee Rating Breakdown in Germany - 5 stars: 10 (100%) - 4 stars: 0 (0%) - 3 stars: 0 (0%) - 2 stars: 0 (0%) - 1 stars: 0 (0%) ## Apps Similar to ADO OncoTobee - [CTCL onkowissen](https://apptail.io/app/ctcl-onkowissen-XYxc/germany) - [Basalzellkarzinom onkowissen](https://apptail.io/app/basalzellkarzinom-onkowissen-YWbd/germany) - [Immunonkologie onkowissen](https://apptail.io/app/immunonkologie-onkowissen-okrd/germany) - [Supportivtherapie onkowissen](https://apptail.io/app/supportivtherapie-onkowissen-plrd/germany) - [CSCC onkowissen](https://apptail.io/app/cscc-onkowissen-dQhf/germany) - [Melanom onkowissen](https://apptail.io/app/melanom-onkowissen-Uwbh/germany) - [Uveales Melanom onkowissen](https://apptail.io/app/uveales-melanom-onkowissen-ROnk/germany) - [Dermatoonkologie onkowissen](https://apptail.io/app/dermatoonkologie-onkowissen-REFn/germany) - [DKK 2024](https://apptail.io/app/dkk-2024-Pnap/germany) - [KOPRA 2024](https://apptail.io/app/kopra-2024-xsnp/germany) ## ADO OncoTobee Available In - [Germany](https://apptail.io/app/ado-oncotobee-SWrn/germany) - [Argentina](https://apptail.io/app/ado-oncotobee-SWrn/argentina) - [Austria](https://apptail.io/app/ado-oncotobee-SWrn/austria) - [Australia](https://apptail.io/app/ado-oncotobee-SWrn/australia) - [Azerbaijan](https://apptail.io/app/ado-oncotobee-SWrn/azerbaijan) - [Belgium](https://apptail.io/app/ado-oncotobee-SWrn/belgium) - [Brazil](https://apptail.io/app/ado-oncotobee-SWrn/brazil) - [Belarus](https://apptail.io/app/ado-oncotobee-SWrn/belarus) - [Canada](https://apptail.io/app/ado-oncotobee-SWrn/canada) - [Switzerland](https://apptail.io/app/ado-oncotobee-SWrn/switzerland) - [Chile](https://apptail.io/app/ado-oncotobee-SWrn/chile) - [China](https://apptail.io/app/ado-oncotobee-SWrn/china) - [Colombia](https://apptail.io/app/ado-oncotobee-SWrn/colombia) - [Czechia](https://apptail.io/app/ado-oncotobee-SWrn/czechia) - [Denmark](https://apptail.io/app/ado-oncotobee-SWrn/denmark) - [Dominican Republic](https://apptail.io/app/ado-oncotobee-SWrn/dominican-republic) - [Algeria](https://apptail.io/app/ado-oncotobee-SWrn/algeria) - [Ecuador](https://apptail.io/app/ado-oncotobee-SWrn/ecuador) - [Estonia](https://apptail.io/app/ado-oncotobee-SWrn/estonia) - [Egypt](https://apptail.io/app/ado-oncotobee-SWrn/egypt) - [Spain](https://apptail.io/app/ado-oncotobee-SWrn/spain) - [France](https://apptail.io/app/ado-oncotobee-SWrn/france) - [United Kingdom](https://apptail.io/app/ado-oncotobee-SWrn/united-kingdom) - [Greece](https://apptail.io/app/ado-oncotobee-SWrn/greece) - [Hong Kong SAR China](https://apptail.io/app/ado-oncotobee-SWrn/hong-kong) - [Croatia](https://apptail.io/app/ado-oncotobee-SWrn/croatia) - [Hungary](https://apptail.io/app/ado-oncotobee-SWrn/hungary) - [Indonesia](https://apptail.io/app/ado-oncotobee-SWrn/indonesia) - [Ireland](https://apptail.io/app/ado-oncotobee-SWrn/ireland) - [India](https://apptail.io/app/ado-oncotobee-SWrn/india) - [Italy](https://apptail.io/app/ado-oncotobee-SWrn/italy) - [Japan](https://apptail.io/app/ado-oncotobee-SWrn/japan) - [South Korea](https://apptail.io/app/ado-oncotobee-SWrn/south-korea) - [Kuwait](https://apptail.io/app/ado-oncotobee-SWrn/kuwait) - [Kazakhstan](https://apptail.io/app/ado-oncotobee-SWrn/kazakhstan) - [Sri Lanka](https://apptail.io/app/ado-oncotobee-SWrn/sri-lanka) - [Luxembourg](https://apptail.io/app/ado-oncotobee-SWrn/luxembourg) - [Latvia](https://apptail.io/app/ado-oncotobee-SWrn/latvia) - [Mexico](https://apptail.io/app/ado-oncotobee-SWrn/mexico) - [Malaysia](https://apptail.io/app/ado-oncotobee-SWrn/malaysia) - [Nigeria](https://apptail.io/app/ado-oncotobee-SWrn/nigeria) - [Netherlands](https://apptail.io/app/ado-oncotobee-SWrn/netherlands) - [Norway](https://apptail.io/app/ado-oncotobee-SWrn/norway) - [New Zealand](https://apptail.io/app/ado-oncotobee-SWrn/new-zealand) - [Philippines](https://apptail.io/app/ado-oncotobee-SWrn/philippines) - [Pakistan](https://apptail.io/app/ado-oncotobee-SWrn/pakistan) - [Poland](https://apptail.io/app/ado-oncotobee-SWrn/poland) - [Portugal](https://apptail.io/app/ado-oncotobee-SWrn/portugal) - [Romania](https://apptail.io/app/ado-oncotobee-SWrn/romania) - [Russia](https://apptail.io/app/ado-oncotobee-SWrn/russia) - [Sweden](https://apptail.io/app/ado-oncotobee-SWrn/sweden) - [Singapore](https://apptail.io/app/ado-oncotobee-SWrn/singapore) - [Slovenia](https://apptail.io/app/ado-oncotobee-SWrn/slovenia) - [Slovakia](https://apptail.io/app/ado-oncotobee-SWrn/slovakia) - [Thailand](https://apptail.io/app/ado-oncotobee-SWrn/thailand) - [Türkiye](https://apptail.io/app/ado-oncotobee-SWrn/turkey) - [Taiwan](https://apptail.io/app/ado-oncotobee-SWrn/taiwan) - [Ukraine](https://apptail.io/app/ado-oncotobee-SWrn/ukraine) - [United Arab Emirates](https://apptail.io/app/ado-oncotobee-SWrn/united-arab-emirates) - [United States](https://apptail.io/app/ado-oncotobee-SWrn/united-states) --- ## About AppTail [AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends. - [Search Apps](https://apptail.io) - [Top Charts](https://apptail.io/top-iphone-apps) - [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&utm_content=footer) *Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*